SI-BONE Past Earnings Performance

Past criteria checks 0/6

SI-BONE's earnings have been declining at an average annual rate of -2.1%, while the Medical Equipment industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 19% per year.

Key information

-2.1%

Earnings growth rate

6.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate19.0%
Return on equity-22.7%
Net Margin-23.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How SI-BONE makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:2K3 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24157-3714717
30 Jun 24151-4114617
31 Mar 24144-4314416
31 Dec 23139-4314115
30 Sep 23132-4413914
30 Jun 23124-4813714
31 Mar 23117-5513913
31 Dec 22106-6113714
30 Sep 22100-6513513
30 Jun 2296-6613213
31 Mar 2292-6212513
31 Dec 2190-5711912
30 Sep 2187-5111212
30 Jun 2185-4510511
31 Mar 2177-439610
31 Dec 2073-44949
30 Sep 2071-44929
30 Jun 2067-46908
31 Mar 2069-42908
31 Dec 1967-38867
30 Sep 1963-35797
30 Jun 1960-28727
31 Mar 1958-23646
31 Dec 1855-17575
30 Sep 1854-17544
30 Jun 1852-18554
31 Mar 1849-21554
31 Dec 1748-23565
31 Mar 1744-21496
31 Dec 1642-21495
31 Mar 1640-27548
31 Dec 1541-28549
30 Sep 1542-32568
31 Mar 1540-32539
31 Dec 1440-28519

Quality Earnings: 2K3 is currently unprofitable.

Growing Profit Margin: 2K3 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2K3 is unprofitable, and losses have increased over the past 5 years at a rate of 2.1% per year.

Accelerating Growth: Unable to compare 2K3's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2K3 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: 2K3 has a negative Return on Equity (-22.67%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 15:33
End of Day Share Price 2025/01/13 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SI-BONE, Inc. is covered by 15 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Craig BijouBofA Global Research
Caitlin CroninCanaccord Genuity
William PlovanicCanaccord Genuity